The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
about
Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockadeRenal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathwaysPossible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathyDiabetes-related microvascular and macrovascular diseases in the physical therapy settingKnockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signalingUric acid as a mediator of diabetic nephropathy.Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic miceRole of upstream stimulatory factor 2 in diabetic nephropathy.Altered dynamics in the renal lymphatic circulation of type 1 and type 2 diabetic miceExosomes from high glucose-treated glomerular endothelial cells activate mesangial cells to promote renal fibrosisAssociations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes.Influence of the Expression of Inflammatory Markers on Kidney after Fetal Programming in an Experimental Model of Renal Failure.TGF-β: the connecting link between nephropathy and fibrosis.C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathyEffects of Free Anthraquinones Extract from the Rhubarb on Cell Proliferation and Accumulation of Extracellular Matrix in High Glucose Cultured-Mesangial Cells.Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes.Role of kidney ADP-ribosyl cyclase in diabetic nephropathy.Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats.Rapeseed protein-derived antioxidant peptide RAP alleviates renal fibrosis through MAPK/NF-κB signaling pathways in diabetic nephropathy.
P2860
Q28482185-9537EE57-2736-4BDA-8579-5BC3001BCDFEQ30427565-14526711-D9D1-47EC-A3B2-B808A342199EQ33637693-26936D02-40E2-4C68-89A3-D375937FD428Q33703845-6441106B-5097-4F51-92DE-A4E9EC3C65A3Q34830905-2D0B9046-41AE-4D00-B5A1-BD289C250636Q35143026-D61F18B0-5C63-477E-8AA8-E722E2196E2BQ35230894-90B99592-524A-4996-BF0E-FF1F67D3B325Q35393446-20AECA46-B4A2-4597-AA58-443891616844Q35549187-37E223A5-22FF-43D5-B235-B1841CA7D9C8Q36175799-16562BE3-9169-4D71-8AE8-026D008CF25FQ36868067-66A34AA4-8EA6-42F8-AF80-CBD9BE01B281Q36961321-ABD5BA2B-87A7-43C0-9981-160CF117F1CAQ37139796-D4D1E9F4-A6A3-4D77-A754-1BBE08866713Q37492648-0A2A6AED-9DBE-4284-911F-E9A2C744FDB4Q38724337-2EB72494-3B78-44C4-A6F0-CE25248448F6Q39903991-4AB961DF-97C4-4909-94E7-DD54B2EECAD6Q42746348-D1483578-2DC9-4DEC-B64F-9E423D26A8D1Q44588651-B07EB7FB-9C24-4D21-A923-7CA7EB5005E0Q44758853-E41D6E7F-4B45-4371-BD09-C7080E4C894CQ46202787-EEE0519E-3E06-4878-AC15-9EFDC9FC671AQ46699745-F1FB1C5C-57F8-416B-B1CA-683490490101Q51347304-492CCFBC-4868-4A1B-B6FD-BBC9E2534166Q53113273-F2702B13-5458-4AD7-B0FF-714937ABBB49Q53260748-14B3AD28-0B20-4BC5-B517-23F8A3750492Q54978317-35EAC398-91A2-4F22-8DC1-012C8F7FFE11
P2860
The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The key role of the transformi ...... nesis of diabetic nephropathy.
@ast
The key role of the transformi ...... nesis of diabetic nephropathy.
@en
The key role of the transformi ...... nesis of diabetic nephropathy.
@nl
type
label
The key role of the transformi ...... nesis of diabetic nephropathy.
@ast
The key role of the transformi ...... nesis of diabetic nephropathy.
@en
The key role of the transformi ...... nesis of diabetic nephropathy.
@nl
prefLabel
The key role of the transformi ...... nesis of diabetic nephropathy.
@ast
The key role of the transformi ...... nesis of diabetic nephropathy.
@en
The key role of the transformi ...... nesis of diabetic nephropathy.
@nl
P2093
P2860
P356
P1433
P1476
The key role of the transformi ...... nesis of diabetic nephropathy.
@en
P2093
Casaretto A
Iglesias-de la Cruz MC
Ziyadeh FN
P2860
P304
P356
10.1081/JDI-100104730
P577
2001-05-01T00:00:00Z